Back

Identification of novel Alzheimer's disease genes co-expressed with TREM2

Reddy, J. S.; Allen, M.; Wang, X.; Biernacka, J. M.; Coombes, B. J.; Jenkins, G. D.; Sinnwell, J. P.; Carrasquillo, M. M.; Pottier, C. P.; Ren, Y.; Sarangi, V.; Younkin, C. S.; Asmann, Y. W.; Ross, O. A.; Rademakers, R.; Golde, T. E.; Ertekin-Taner, N.; Steven, Y. G.

2020-11-15 genetics
10.1101/2020.11.13.381640 bioRxiv
Show abstract

By analyzing whole-exome data from the Alzheimers disease sequencing project (ADSP), we identify a set of 4 genes that show highly significant association with Alzheimers disease (AD). These genes were identified within a human TREM2 co-expression network using a novel approach wherein prioritized polygenic score analyses were performed sequentially to identify significant polygenic components. Two of the 4 genes (TREM2, RIN3) have previously been linked to AD and two (ATP8B4, IL17RA) are novel. Like TREM2, the 2 novel AD genes are selectively expressed in human microglial cells. The most significant variants in ATP8B4 and IL17RA are non-synonymous variants with strong effects comparable to the APOE {varepsilon}4 and {varepsilon}2 alleles. These protein-altering variants will provide unique opportunities to further explore the biological role of microglial cells in AD and help inform future immune modulatory therapeutic development for AD.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.